Dengue Vaccine Candidate Meets Primary Efficacy Endpoint in Phase 3 Study - Contagionlive.com

Dengue Vaccine Candidate Meets Primary Efficacy Endpoint in Phase 3 Study  Contagionlive.com

Takeda Pharmaceutical Company Limited has announced that an investigational dengue vaccine has met the primary efficacy endpoint in an ongoing Phase 3 ...



Comments

Popular posts from this blog

Marburg virus disease

Ringworm Pictures: What a Ringworm Rash Looks Like - WebMD